false
Catalog
2022 World Conference on Lung Cancer (ePosters)
EP08.02-117. Online CME Improves Clinicians' Abili ...
EP08.02-117. Online CME Improves Clinicians' Ability to Identify and Manage Patients with NSCLC and EGFR Exon 20 Insertion Mutations
Back to course
Pdf Summary
A series of online, CME-certified activities were successful in improving the knowledge, competence, and confidence of oncologists, pathologists, and pulmonologists regarding the identification and management of patients with non-small cell lung cancer (NSCLC) and EGFR exon 20 insertion mutations. These mutations are associated with resistance to available EGFR inhibitors. The educational series, developed in collaboration with Medscape Oncology, IASLC, and AMP, resulted in measurable improvements in clinical care. Additional educational activities were identified to address remaining gaps and further enhance clinicians' abilities in this clinical setting.<br /><br />The study assessed the educational impact of the CME activities through pre-/post-education assessments, including multiple-choice knowledge/competence questions and confidence ratings on a Likert scale. The data from oncologists, pathologists, and pulmonologists who completed the assessments were analyzed to measure improvement in knowledge, competence, and confidence. The results showed significant improvements in understanding relevant clinical trial data, identifying mutations, and recognizing the role of EGFR exon 20 insertion mutations in NSCLC.<br /><br />The study also highlighted the need for ongoing education to address remaining gaps and reinforce knowledge and competence. The educational activities were found to reinforce knowledge and current practices in addition to improving them. The results indicated that the CME activities led to improved diagnostic competence in identifying EGFR exon 20 insertion mutations in NSCLC and increased confidence in recognizing the role of these mutations in the disease.<br /><br />Overall, the study demonstrated that online CME activities can effectively enhance clinicians' ability to identify and manage patients with NSCLC and EGFR exon 20 insertion mutations. The findings have implications for improving clinical care and addressing the unmet needs of patients with these specific mutations. Additional educational efforts are warranted to further enhance clinicians' abilities in this area.
Asset Subtitle
Michelle Arielle Worst
Meta Tag
Speaker
Michelle Arielle Worst
Topic
Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
Keywords
online CME activities
non-small cell lung cancer
EGFR exon 20 insertion mutations
clinical care
oncologists
pathologists
pulmonologists
knowledge improvement
competence enhancement
confidence boost
×
Please select your language
1
English